Contineum Therapeutics, Inc.
CTNM • NASDAQ
Contineum Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Carmine N. Stengone, with a market cap of $479.0M.
Market Cap$479.0M
CEOCarmine N. Stengone
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Contineum Therapeutics, Inc. FAQ
Common questions about Contineum Therapeutics, Inc.
Contineum Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 13, 2026.